PenderFund Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

PenderFund Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-27,800	Closed	-$563K	–	180
2022 Q4	$563K	Buy	+27,800	New	+$385K	0.17%	68

PenderFund Capital Management's AVEO Position: Q1 2023 in Review

PenderFund Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 27,800 shares — an estimated $563K sold.

PenderFund Capital Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $563K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

PenderFund Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
PenderFund Capital Management sold 27,800 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $563K.
PenderFund Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
PenderFund Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $563K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on PenderFund Capital Management's 13F filing for Q1 2023, filed 15 May 2023.